机构:[1]Laboratory of Stem Cell Biology, and Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University Chengdu, Chengdu, 610041, P. R. China.四川大学华西医院[2]School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.[3]Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.[4]Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA, 91711, USA.
This work was supported
by National Natural Science Foundation of China (51703245, 81701807,
51873120, 51673127, and 81621003), Natural Science Foundation of Fujian Province (2020J01621), and Natural Science Foundation of Jiangsu
Province (BK20170733). This research was funded by West China Hospital
of Sichuan University (ZYGD18028 and 2020HXBH072) and the Research
Initiate Funds of Fujian Medical University (XRCZX2020001)
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|3 区化学
小类|2 区高分子科学
最新[2023]版:
大类|3 区化学
小类|3 区高分子科学
第一作者:
第一作者机构:[1]Laboratory of Stem Cell Biology, and Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University Chengdu, Chengdu, 610041, P. R. China.[2]School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Li Ning,Duan Zhenyu,Wang Lili,et al.An Amphiphilic PEGylated Peptide Dendron-Gemcitabine Prodrug-Based Nanoagent for Cancer Therapy.[J].Macromolecular rapid communications.2021,42(12):e2100111.doi:10.1002/marc.202100111.
APA:
Li Ning,Duan Zhenyu,Wang Lili,Guo Chunhua,Zhang Hu...&Luo Kui.(2021).An Amphiphilic PEGylated Peptide Dendron-Gemcitabine Prodrug-Based Nanoagent for Cancer Therapy..Macromolecular rapid communications,42,(12)
MLA:
Li Ning,et al."An Amphiphilic PEGylated Peptide Dendron-Gemcitabine Prodrug-Based Nanoagent for Cancer Therapy.".Macromolecular rapid communications 42..12(2021):e2100111